Analysis of CMV-specific T-cell reconstitution following BMT to identify patients risk of late onset CMV disease

被引:0
|
作者
Hebart, H
Krause, H
Wagner, I
Muller, CA
Jahn, G
Einsele, H
机构
[1] MED KLIN & POLIKLIN,TUBINGEN,GERMANY
[2] INST KLIN & EPIDEMIOL VIRUSKRANKHEITEN,TUBINGEN,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:852 / 852
页数:1
相关论文
共 50 条
  • [1] Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease
    Krause, H
    Hebart, H
    Jahn, G
    Muller, CA
    Einsele, H
    BONE MARROW TRANSPLANTATION, 1997, 19 (11) : 1111 - 1116
  • [2] Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease
    H Krause
    H Hebart
    G Jahn
    CA Müller
    H Einsele
    Bone Marrow Transplantation, 1997, 19 : 1111 - 1116
  • [3] Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients
    Veit, Tobias
    Pan, Ming
    Munker, Dieter
    Arnold, Paola
    Dick, Andrea
    Kunze, Susanne
    Meiser, Bruno
    Schneider, Christian
    Michel, Sebastian
    Zoller, Michael
    Boehm, Stephan
    Walter, Julia
    Behr, Juergen
    Kneidinger, Nikolaus
    Kauke, Teresa
    CLINICAL TRANSPLANTATION, 2021, 35 (06)
  • [4] CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
    Luo, Xiao-Hua
    Zhu, Yan
    Chen, Yu-Ting
    Shui, Li-Ping
    Liu, Lin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] CMV-specific immune reconstitution following allogeneic stem cell transplantation
    Blyth, Emily
    Withers, Barbara
    Clancy, Leighton
    Gottlieb, David
    VIRULENCE, 2016, 7 (08) : 967 - 980
  • [6] CMV-Specific T-Cell Immunity and CMV NAAT in Assignment of CMV Status in Pediatric SOT Candidates
    Burton, C.
    Preiksaitis, J.
    Sester, M.
    Tong, Y.
    Wong, E.
    Urschel, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S274 - S274
  • [7] A CMV-Specific T-Cell Assay Can Predict Future Recurrence of CMV in Liver Transplant Patients
    Sood, S.
    Haifer, C.
    Yu, J.
    Pavlovic, J.
    Gow, P.
    Jones, R.
    Visvanathan, K.
    Angus, P.
    Testro, A.
    TRANSPLANTATION, 2014, 98 : 179 - 179
  • [8] A CMV-Specific T-Cell Assay Can Predict Future Recurrence of CMV in Liver Transplant Patients
    Sood, S.
    Haifer, C.
    Yu, J.
    Pavlovic, J.
    Gow, P.
    Jones, R.
    Visvanathan, K.
    Angus, P.
    Testro, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 179 - 179
  • [9] CMV-Seropositive patients allografted with a CMV-seronegative donor show delayed or missing CMV-specific T-Cell immune response and are at higher risk for CMV-viremia and CMV-disease.
    Ganepola, S
    Gentilini, C
    Hilbers, U
    Hartung, G
    Lange, T
    Hofmann, J
    Liebert, UG
    Hammer, M
    Engelmann, E
    Niederwieser, D
    Thiel, E
    Uharek, L
    BLOOD, 2005, 106 (11) : 908A - 908A
  • [10] CMV-specific T cell therapy
    Einsele, Hennann
    Kapp, Markus
    Grigoleit, Goetz Ulrich
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (01) : 71 - 75